The Knockoff GLP-1 Market Is Still the Wild West
The Knockoff GLP-1 Market Is Still the Wild West is drawing significant interest across the industry.
Telehealth company Hims & Hers unleashed a wild few days in the obesity drug market last week when it introduced a cheap, compounded version of Novo Nordisk’s new Wegovy pill.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Charting the widening impact of the Iran crisis on energy markets
- Sensex, Nifty: 3 reasons why stock market is staring at selloff today
- Is this ASX materials stock a buy after soaring 10% yesterday?
- The British stock market's full of hidden gems... let me help you unearth them, says money guru JEFF PRESTRIDGE. UK shares are up 25pc in a year... but these potential winners are still dirt-cheap
Source: Original →